Results 141 to 150 of about 13,138 (168)

Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD

Diabetes Care, 2022
, Francisca Saraiva, FRANCISCO Vasques-Nóvoa   +2 more
exaly  

Fenofibrate

Reactions Weekly, 1991
openaire   +1 more source

Impact of fenofibrate on NAFLD/NASH: A genetic perspective

Drug Discovery Today, 2022
Ali Mahmoudi, Amirhossein Sahebkar, Thomas P Johnston   +2 more
exaly  

A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease

Digestive and Liver Disease, 2008
F Colina, C Fernandez-Miranda
exaly  

Fenofibrate

Reactions Weekly, 2015
  +4 more sources

Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

European Heart Journal, 2010
Elizabeth Williamson, Diana Zannino, Timothy Davis   +2 more
exaly  

Effect of Fenofibrate on Kidney Function: A 6-Week Randomized Crossover Trial in Healthy People

American Journal of Kidney Diseases, 2008
R Neil Dalton, Jean-Claude Ansquer
exaly  

Fenofibrate and the kidney: an overview

European Journal of Clinical Investigation, 2013
Michalis Kostapanos, Moses Elisaf
exaly  

Fenofibrate

Reactions Weekly, 2016
openaire   +2 more sources

Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial

Atherosclerosis, 2016
Bela Asztalos, Ernst Schaefer, Fumiyoshi Tsunoda   +2 more
exaly